CSafe Global has announced the appointment of Abigail French as the company’s newest Director of Strategic Life Science Sales. Mrs. French, who is based in North Carolina, will be responsible for contributing to CSafe's overall business growth while she consults with the regions biopharma, medical device, and partner companies. With extensive experience in biotech, pharmaceutical, medical device, and temperature control markets, Abigail will be an integral participant of the company’s global market penetration strategy.
Before joining CSafe, Abigail held top performing sales positions within LABRepCo, Covidien/Medtronic, and Aventis. “I am extremely impressed with the CSafe Global portfolio of cold chain solutions and its unrivalled value proposition", remarked Abigail. "It’s an exciting time. CSafe is uniquely positioned as the only global manufacturer with a full suite of both active and passive temperature management solutions. I’ve been in this industry a long time and to join a company that’s completely committed seeking the best solutions without limiting their options to one particular technology is exciting!”
CSafe Global has become the world leader in temperature-controlled containers for sensitive pharma and medical products and this new appointment is part of the company's ambitious expansion plans. With its principal biopharma market continuing to grow significantly, the company is investing heavily in expanding its international footprint and in pioneering innovative, market-leading solutions.
Commenting on the new appointment, Nadine Siqueland, Vice President of Global Sales said: "Abigail is an excellent addition to our growing and experienced team and will contribute substantial sales management experience and expertise. As a President’s Club top-performer with a consultative approach, Abigail will bring great value to our fast-growing, world-class team.” Nadine went on to share: “Much of our exponential growth is driven by Life Science companies and partners that increasingly choose to work with CSafe as a single-source partner, recognizing our unique ability to problem solve their most complex cold chain challenges with both active and passive cold chain solutions. They understand that we are focused on serving their patients who are receiving critical, life-saving biopharmaceutical, biosimilar and medical device treatments that require the most robust solutions. There is no other global manufacturer with the breadth and depth of cold chain offerings that CSafe brings, which is why on-boarding talented professionals like Abigail, who will leverage her deep industry knowledge to further expand our market growth lead, is so important.”